Basket and Umbrella Trials for Oncology

Register: Link

CBI’s Basket and Umbrella Trials for Clinical Oncology will convene the key stake holders looking at adoption to share strategies to quickly overcome these hurdles, and foster adoption.

Much of the pharmaceutical industry would agree that uncompleted clinical trials are one of the biggest hurdles in oncology drug development. The ramifications of an uncompleted trial can stretch across an organization, covering lost investments, loss of regulatory confidence, increased timelines, and patient impacts.

Basket and Umbrella trials have emerged as a potential solution to many of these headaches, but adoption is not a simple path. High startup costs, complex protocols, contract difficulties, and regulatory approval are but a few of the major challenges.

Date: October 17-18, 2018
Location: Philadelphia, PA
lorem ipsum